CORC  > 吉林大学白求恩第三医院
Clinical efficacy analysis of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in primary liver cancer and recurrent liver cancer
Ji, Shangwei; Sun, Yu; Liu, Lin; Lie, Chunsheng; Jig, Hong
刊名JOURNAL OF BUON
2019
卷号24期号:4
关键词hepatocellular carcinoma transcatheter arterial chemoembolization radiofrequency ablation prognosis
ISSN号1107-0625
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3511533
专题吉林大学白求恩第三医院
推荐引用方式
GB/T 7714
Ji, Shangwei,Sun, Yu,Liu, Lin,et al. Clinical efficacy analysis of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in primary liver cancer and recurrent liver cancer[J]. JOURNAL OF BUON,2019,24(4).
APA Ji, Shangwei,Sun, Yu,Liu, Lin,Lie, Chunsheng,&Jig, Hong.(2019).Clinical efficacy analysis of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in primary liver cancer and recurrent liver cancer.JOURNAL OF BUON,24(4).
MLA Ji, Shangwei,et al."Clinical efficacy analysis of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in primary liver cancer and recurrent liver cancer".JOURNAL OF BUON 24.4(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace